US 12,682,101 · Application 19/412,965 · Granted Jul 14, 2026
US 12,682,101
Streamlined evaluation of simultaneously executed artificial intelligence agents
Estimated expiration
August 19, 2044
17y 300d remaining
- DataLab client not configured; cannot parse TD PDFs for referenced patents
Earliest effective filing
Aug 19, 2024
+ 20 years
Aug 19, 2044
PTA +0d
Aug 19, 2044
No TD
—
Final
Aug 19, 2044
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- December 9, 2025
- Earliest effective filing
- August 19, 2024
- Issue date
- July 14, 2026
- PTA
- 0 days
- Base expiry (before PTA)
- August 19, 2044
August 19, 2024 + 20 years = August 19, 2044
- Continuation of application 18/809,261, filed Aug 19, 2024, issued as US 12,511,458
- PRO63/658,434 — Provisional — not used for base term
- PRO63/650,487 — Provisional — not used for base term
- PRO63/658,434 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 19/412,965 · US 12,682,101
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,682,101: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12682101Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.